Glycaemic management in diabetes: old and new approaches
Ceriello A, Prattichizzo F, Phillip M, et al.
Lancet Diabetes Endocrinol. 2021;S2213-8587(21)00245-X.
Leggi
Continuous glucose monitoring systems for monitoring cystic fibrosis‐related diabetes
Toner A, McCloy A, Dyce P
Cochrane Database Syst Rev. 2021;11(11):CD013755.
Leggi
Comparison of mortality in people with type 1 and type 2 diabetes by age of diagnosis: an incident population-based study in England and Wales
Holman N, Wild SH, Gregg EW
Lancet Diabetes Endocrinol. 2021;S2213-8587(21)00293-X.
Leggi
Are statins indicated in senior citizens? A review of statin therapy in the elderly
Wylie LE, Waterbrook AL, Dalen JE
Am J Med. 2021;S0002-9343(21)00790-7.
Leggi
Telehealth for people with diabetes: poised for a new approach
Hood KK, Wong JJ
Lancet Diabetes Endocrinol. 2021;S2213-8587(21)00312-0.
Leggi
SURVEY DISLIPIDEMIE E DIABETE
Con la progressiva crescita delle evidenze scientifiche che, in maniera univoca, mostrano un rapporto causale tra i livelli di colesterolo legato alle lipoproteine a bassa densità (C- LDL) e gli eventi cardiovascolari, il C-LDL è diventato obiettivo terapeutico cruciale, valorizzando pienamente la prospettiva cardiometabolica. Le terapie con statine e/o ezetimibe,…
Leggi